Article Details
Retrieved on: 2022-08-24 09:17:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here